Old Web
English
Sign In
Acemap
>
authorDetail
>
Susan W. Burriss
Susan W. Burriss
GlaxoSmithKline
Internal medicine
Medicine
Adverse effect
Placebo
Pharmacodynamics
4
Papers
15
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A randomised, placebo-controlled study of RIPK1 inhibitor GSK2982772 in patients with active ulcerative colitis
2021
BMJ Open Gastroenterology
Kathy Weisel
Nicola Scott
Scott B. Berger
Susanne Wang
Kurt Brown
Marcy Powell
Matthijs Broer
Clarissa J. Watts
Debra J. Tompson
Susan W. Burriss
Simon Hawkins
Kathy Abbott-Banner
Paul P. Tak
Show All
Source
Cite
Save
Citations (1)
10 Years of belimumab experience: What have we learnt?:
2021
Lupus
Roger A Levy
Tania Gonzalez-Rivera
Munther Khamashta
N.L. Fox
Angela Jones-Leone
Bernie Rubin
Susan W. Burriss
Kerry Gairy
André van Maurik
David M. Roth
Show All
Source
Cite
Save
Citations (3)
A randomized, placebo-controlled experimental medicine study of RIPK1 inhibitor GSK2982772 in patients with moderate to severe rheumatoid arthritis.
2021
Arthritis Research & Therapy
Kathleen M. Weisel
Scott B. Berger
Katie Thorn
Peter C. Taylor
Charles Peterfy
Hilary Siddall
Debra J. Tompson
Susanne Wang
Emilia Quattrocchi
Susan W. Burriss
Jochen Walter
Paul P. Tak
Show All
Source
Cite
Save
Citations (7)
EMBRACE: Phase 3/4, Randomized, 52-Week Study of Belimumab Efficacy and Safety in Patients of Black African Ancestry With Systemic Lupus Erythematosus
2021
Arthritis & Rheumatism
Ellen M. Ginzler
Luiz Sergio Guedes Barbosa
David DCruz
Richard Furie
Kathleen Maksimowicz-McKinnon
Jim C. Oates
Mittermayer Barreto Santiago
Amit Saxena
Saira Z. Sheikh
Damon Bass
Susan W. Burriss
Jennifer A Gilbride
J. Groark
Michelle Miller
Amy Pierce
David M. Roth
Beulah Ji
Show All
Source
Cite
Save
Citations (4)
1